Abstract:MicroRNAs (miRNAs) constitute a family of small non-coding ribonucleic acids that are post-transcriptional regulators of messenger RNA (mRNA) complexity. While miRNAs are known to be dynamically regulated during CNS development, the roles of specific miRNAs in CNS aging and neurodegeneration are not well understood. This study examined miRNA abundance and signaling circuitry in Alzheimer's disease (AD) brain, in cytokine-, Aβ42- and ROS-stressed human neural primary cell lines and in Tg2576 transgenic mice fed a high-fat cholesterol (HFC) diet. AD and age-matched control post-mortem brain tissue; IL-1β, Aβ42 and ROS-stressed human neural (HN) cells in primary culture; high-fat cholesterol (HFC) diet stressed Tg2576 mice; total DNA, RNA and protein isolation and quality control; DNA arrays (Affymetrix, Santa Clara, CA); micro RNA (miRNA) arrays (LC Sciences, Houston, TX); miRNA panels; Northern analysis; RT-PCR; Western Immunoblotting; gel shift assay; miRNA construct transfection vectors; specific NF–κB and inflammatory transcription factor repression; bioinformatics (Sanger miRBASE, Cambridge UK). Of the total number of miRNAs expressed in the human brain, only a selective subset appear to be altered in the AD process. miRNAs encoding miR-9, miR-124a, miR-125b, miR-128, miR-132 and miR-219 were found to be abundantly represented in fetal hippocampus however they exhibited differential regulation in Alzheimer hippocampus. Specific increases in the abundance of miRNA-146a was found to coincide with down-regulation in the abundance of one prominent miRNA-146a target, complement factor H (CFH) mRNA, encoding an important regulatory glycoprotein in the brain's complement and inflammatory response. Promoter mapping, inhibitor studies and transfection-reporter studies showed that miRNA-146a is an NF–κB-sensitive gene. We also observed a specific up-regulation of miRNA-146a in cytokine IL-1β- and Aβ42-stressed human neural cells and in HFC-stressed Tg2576 mice, an effect that was reversed in part by the cholesterol biosynthesis inhibitor simvastatin. These data are consistent with the idea that altered miRNA-mediated processing of mRNA populations may contribute to atypical mRNA abundance, neural dysfunction and inflammatory signaling pathways in Alzheimer's disease. The use of anti-miRNA pharmacotherapeutic strategies are attractive because they have potential to silence entire families of pro-inflammatory pathogenic genes in Alzheimer's disease brain. Supported in part by NIA AG18031.

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

MicroRNA-139 Modulates Alzheimer's-associated Pathogenesis in SAMP8 Mice by Targeting Cannabinoid Receptor Type 2.

Genome-wide Analysis of Mirna Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

Downregulation of miR-181c-5p in Alzheimer's disease weakens the response of microglia to Aβ phagocytosis

MicroRNA-338-5p Alleviates Neuronal Apoptosis Via Directly Targeting BCL2L11 in APP/PS1 Mice

Loss of miR-369 Promotes Tau Phosphorylation by Targeting the Fyn and Serine/Threonine-Protein Kinase 2 Signaling Pathways in Alzheimer’s Disease Mice

Microrna-34A (Mirna-34A) Mediated Down-Regulation of the Post-synaptic Cytoskeletal Element SHANK3 in Sporadic Alzheimer's Disease (AD)

MicroRNAs: Pioneering Regulators in Alzheimer’s Disease Pathogenesis, Diagnosis, and Therapy

MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy

microRNA‐425 loss mediates amyloid plaque microenvironment heterogeneity and promotes neurodegenerative pathologies

Post‐transcriptional Regulation of Α7 Nachr Expression by Mir‐98‐5p Modulates Cognition and Neuroinflammation in an Animal Model of Alzheimer's Disease

Peripheral Blood MicroRNA Expression Profiles in Alzheimer’s Disease: Screening, Validation, Association with Clinical Phenotype and Implications for Molecular Mechanism

Role of miR-211 in Neuronal Differentiation and Viability: Implications to Pathogenesis of Alzheimer's Disease.

Elevated Levels of miR-144-3p Induce Cholinergic Degeneration by Impairing the Maturation of NGF in Alzheimer’s Disease

Human microRNA (miR-20b-5p) modulates Alzheimer’s disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer’s biomarkers

miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease

O2-03-06: Micro RNA-146A–mediated Signaling in Alzheimer's Disease

MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects

The Regulation of Micrornas in Alzheimer's Disease

miR-30a-5p induces Aβ production via inhibiting the nonamyloidogenic pathway in Alzheimer’s disease

miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease.